Literature DB >> 4213977

Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.

S C Schimpff, W H Greene, V M Young, P H Wiernik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4213977     DOI： 10.1093/infdis/130.supplement.s24

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  Do double-beta-lactam combinations prolong neutropenia in patients undergoing chemotherapy or bone marrow transplantation for hematological disease?

Authors:  C C Kibbler; H G Prentice; R J Sage; A V Hoffbrand; M K Brenner; P Noone
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

2.  T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.

Authors:  W G Powderly; G B Pier; R B Markham
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Molecular epidemiological study of Pseudomonas aeruginosa isolates from patients with acute leukemia.

Authors:  W Kern; C Wolz; G Döring
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

4.  Management of the febrile neutropenic patient.

Authors:  L A Mandell
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

5.  Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice.

Authors:  G C Tsay; M S Collins
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

6.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Murine gastrointestinal tract as a portal of entry in experimental Pseudomonas aeruginosa infections.

Authors:  L B Schook; L Carrick; R S Berk
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

8.  Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.

Authors:  S C Schimpff; S Landesman; D M Hahn; H C Standiford; C L Fortner; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

9.  Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.

Authors:  C E Lopez; H C Standiford; B A Tatem; F M Calia; S C Schimpff; M J Snyder; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

10.  In vivo distribution of Pseudomonas aeruginosa slime glycolipoprotein: association with leukocytes.

Authors:  M Lynn; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.